Fukuda Denshi CoFKDSF 83 Pretax Margin % is 24.95% as of Mar. 2026, which is 54% above its 10-year median of 16.15. GuruFocus rates FKDSF with a GF Score™ of 83/100 and a GF Value™ of $27.75. The stock has 4 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Fukuda Denshi Co ranks better than 84.09% on this metric.
The historical rank and industry rank for Fukuda Denshi Co's Pretax Margin % or its related term are showing as below:
FKDSF'
s Pretax Margin % Range Over the Past 10 Years
Min: 9.92 Med: 16.15 Max: 19.51
Current: 19.35
FKDSF's Pretax Margin % is ranked better than 84.09% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.4
vs FKDSF: 19.35
Fukuda Denshi Co (OTCPK:FKDSF) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Fukuda Denshi Co Pretax Margin % Related Terms
Fukuda Denshi Co Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Fukuda Denshi Co's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FKDSF vs ABT, SYK, MDT: Pretax Margin % Comparison
For the Medical Devices subindustry, Fukuda Denshi Co's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fukuda Denshi Co Pretax Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Fukuda Denshi Co's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Fukuda Denshi Co's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fukuda Denshi Co (FKDSF) has a Pretax Margin % of 24.95% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Fukuda Denshi Co and its competitors. This is 54% above median its historical median of 16.15. Over the past decade, Fukuda Denshi Co's Pretax Margin % has ranged from 9.92 to 19.51. According to the industry distribution chart, Fukuda Denshi Co ranks #130 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 15.9%.
Is Fukuda Denshi Co's Pretax Margin % too high?
Fukuda Denshi Co's current Pretax Margin % of 24.95% is 54% above median its 10-year median of 16.15. Over the past 10 years, this metric has ranged from a low of 9.92 to a high of 19.51. The Medical Devices & Instruments industry median Pretax Margin % is 2.40. Fukuda Denshi Co's value of 24.95% is 939.6% above this industry median. Based on the distribution chart, Fukuda Denshi Co ranks #130 out of 817 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Fukuda Denshi Co has a GF Score™ of 83/100, reflecting its overall financial health beyond just this single metric.
How does Fukuda Denshi Co's Pretax Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Fukuda Denshi Co ranks #130 out of 817 companies for Pretax Margin %. This places Fukuda Denshi Co in the top 16% of its industry — outperforming the majority of peers. The industry median Pretax Margin % is 2.40. Fukuda Denshi Co's value of 24.95% is 939.6% above this benchmark. Historically, Fukuda Denshi Co's own Pretax Margin % has ranged from 9.92 to 19.51 over the past decade. While the company's 10-year median is 16.15 vs. the industry median of 2.40, Fukuda Denshi Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Devices & Instruments company?
The median Pretax Margin % among Medical Devices & Instruments companies is 2.40, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fukuda Denshi Co's current Pretax Margin % of 24.95% is 939.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Fukuda Denshi Co and its competitors. For the Medical Devices & Instruments industry, the median Pretax Margin % is 2.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fukuda Denshi Co's current Pretax Margin % is 24.95%, which is 54% above median its own 10-year median of 16.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fukuda Denshi Co stock overvalued right now?
Fukuda Denshi Co (FKDSF) has a current Pretax Margin % of 24.95%. The stock's GF Value™ is $27.75, compared to a current price of $42.55 — trading 53.3% above its estimated fair value. The current Pretax Margin % is 24.95%, which is 54% above median its 10-year median of 16.15 and 939.6% above the Medical Devices & Instruments industry median of 2.40. Fukuda Denshi Co's overall GF Score™ is 83/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Fukuda Denshi Co (FKDSF), the current Pretax Margin % is 24.95% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fukuda Denshi Co (FKDSF) Overvalued in 2026?
Based on GuruFocus' analysis, Fukuda Denshi Co stock appears to be overvalued.
The current stock price of $42.55 is trading 53.3% above its estimated GF Value™ of $27.75.
Key valuation signals for FKDSF:
Pretax Margin %: 24.95% (54% above median its 10-year median of 16.15)
GF Value™: $27.75 vs. price of $42.55 (53.3% above fair value)
Industry Position: 939.6% above the Medical Devices & Instruments median (#130 of 817)
No single metric tells the full story. See the FKDSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fukuda Denshi Co Ltd develops and manufactures medical electronic equipment. The firm operates in four segments: physiological diagnostic equipment, patient monitoring equipment, medical treatment equipment, and consumables and other products. The physiological diagnostic equipment business sells electrocardiographs, vascular screening systems, and blood cell counters. The patient monitoring equipment segment sells patient monitors and transmitters. The medical treatment equipment segment contributes the largest proportion of revenue and sells pacemakers and medical equipment for home treatment. The consumables and other products segment sells disposable electrodes and consumables used for the firm's devices. Fukuda Denshi generates the vast majority of its sales in Japan.
83GF Score
Get the complete analysis for FKDSF
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FKDSF has been successfully added to your 
